Real-World Data on the Effectiveness of Ustekinumab and Risankizumab for Crohn’s Disease
<p>Introduction: No real-world studies have compared efficacy of ustekinumab (UST) and risankizumab (RZB) for the treatment of Crohn’s disease (CD). Methods: We retrospectively collected the data of patients with CD treated with UST or RZB between May 2017 and March 2024 at the Institute...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Karger Publishers
2025-01-01
|
| Серии: | Inflammatory Intestinal Diseases |
| Online-ссылка: | https://karger.com/article/doi/10.1159/000547048 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|